| ¿µ¹® | systemic circulation | ÇÑ±Û | ü¼øÈ¯ |
|---|---|---|---|
| ¼³¸í | ¿Þ½É½Ç¿¡¼ ½Åü¸¦ µ¹¾Æ ¿À¸¥½É¹æ±îÁöÀÇ ¼øÈ¯À» ÀǹÌÇϸç, ¿Þ½É½Ç ¡æ ´ëµ¿¸Æ ¡æ µ¿¸Æ ¡æ ¸ð¼¼Ç÷°ü ¡æ Á¤¸Æ ¡æ ´ëÁ¤¸Æ ¡æ ¿À¸¥½É¹æÀÇ È¸·Î¸¦ ¼øÈ¯ÇÑ´Ù. |
||
| ¿µ¹® | extracorporeal circulation | ÇÑ±Û | ü¿Ü¼øÈ¯, ¸ö¹Û¼øÈ¯ |
|---|---|---|---|
| ¼³¸í | ü¿ÜÀÇ ÀΰøÈ¸·Î¸¦ µû¶ó ÀÌ·ç¾îÁö´Â ¼øÈ¯¹ý. Ç÷°ü³»¿¡ »ðÀÔÇÑ Æ©ºê¸¦ ÅëÇÏ¿© Ç÷¾×À» ÀÏ´Ü Ã¼¿Ü·Î ³»º¸³»¼, ÆßÇÁ¿¡ ÀÇÇÏ¿© ¿¬¼ÓÇÏ¿© ÀçÂ÷ ü³»¿¡ µÇµ¹¸®´Â ¼øÈ¯À» ü¿Ü¼øÈ¯À̶ó°í ÇÑ´Ù. ¿©·¯ °¡ÁöÀÇ ¸ñÀûÀ» À§ÇÏ¿© »ç¿ëµÇ¸ç, ¿©·¯ °¡ÁöÀÇ ¹æ½ÄÀÌ ÀÖ´Ù. °¡Àå ³Î¸® »ç¿ëµÇ°í ±âº»À¸·Î µÇ¾î ÀÖ´Â °ÍÀº, Àΰø½ÉÆó¿¡ ÀÇÇÑ Ã¼¿Ü¼øÈ¯À¸·Î »ó-ÇÏ´ëÁ¤¸Æ¿¡ »ðÀÔÇÑ »ð°üÀ» ÅëÇÏ¿© ½ÉÀåÀ¸·Î µÇµ¹¾Æ°¡´Â Á¤¸ÆÇ÷À» ü¿Ü¿¡ ÀÖ´Â »ê¼ÒÈÀåÄ¡·Î À̲ø¾î¼ »ê¼Ò¸¦ °¡ÇÑ ÈÄ, ÆßÇÁ¿¡ ÀÇÇÏ¿© µ¿¸Æ³»·Î º¸³»´Â ¹æ½ÄÀ¸·Î ½ÉÀåÀ¸·ÎÀÇ È¯·ùÇ÷ÀÇ ÀüºÎ¸¦ »ê¼ÒÈÀåÄ¡·Î À̲ô´Â °æ¿ì¸¦ ¿ÏÀüü¿Ü¼øÈ¯, ÀϺκи¸À» À̲ô´Â °æ¿ì¸¦ ºÎºÐü¿Ü¼øÈ¯À̶ó°í ÇÑ´Ù. À̿ܿ¡ Á½ɵθ§±æ¹ý, ¿ì½ÉµÎ¸§±æ¹ý, ½ÅüÀÇ ÀϺκи¸ÀÇ Ã¼¿Ü¼øÈ¯, º¸Á¶¼øÈ¯µîÀÌ ÀÖ´Ù. |
||
| ¿µ¹® | pulmonary circulation | ÇÑ±Û | Æó¼øÈ¯ |
|---|---|---|---|
| ¼³¸í | Àü½Å¼øÈ¯À» °ÅÄ£ »ê¼ÒºÐ¾ÐÀÌ ³·Àº Á¤¸ÆÇ÷ÀÌ ¿À¸¥½É¹æÀ¸·Î µé¾î¿Í ¿À¸¥½É½ÇÀ» °ÅÃÄ Æóµ¿¸ÆÀ» ÅëÇÏ¿© Æó·Î °¡¼ °¡½º ±³È¯À» ÇÑ ÈÄ, »ê¼ÒºÐ¾ÐÀÌ ³ôÀº µ¿¸ÆÇ÷ÀÌ µÇ¾î ÆóÁ¤¸ÆÀ» Ÿ°í ´Ù½Ã Á½ɹæÀ¸·Î µ¹¾Æ¿À´Â Ç÷¾×ÀÇ ¼øÈ¯°úÁ¤À» À̸£´Â ¸»ÀÌ´Ù. |
||
| ¿µ¹® | obsessive-compulsive disorder | ÇÑ±Û | °¹Ú¹ÝÀÀ¼º Àå¾Ö |
|---|---|---|---|
| ¼³¸í | °¹Ú»ç°í(obsession)Àº ¹Ýº¹µÇ´Â »ç°í¸¦ ¸»Çϸç, °¹ÚÇàÀ§(compulsion)´Â ¹Ýº¹µÇ´Â ÇൿÀ» ¸»ÇÑ´Ù. Áï ¹Ýº¹µÇ´Â »ç°í¿¡ µû¶ó ¹Ýº¹ÀûÀÎ ÇൿÀ» ¼öÇàÇÏ´Â Àå¾Ö¸¦ ¸»ÇÑ´Ù. À̶§ ¹Ýº¹ÀûÀÎ »ç°í´Â ÀÌ·ÐÀûÀ¸·Î ÀÌÇØµÇÁö ¾Ê´Â °æ¿ì°¡ ¸¹°í, º»Àεµ ÀÌ·± »ç°í°¡ ÀÌÇØµÇÁö ¾Ê´Â´Ù´Â »ç½ÇÀ» ¾Ë°í °íÄ¡·Á°í ÇÏÁö¸¸, Àß µÇÁö ¾Ê´Â´Ù. ¶ÇÇÑ °è¼ÓÀûÀ¸·Î ÀÌ·± »ç°í¿¡ µû¸¥ ¹Ýº¹ÀûÀÎ ÇൿÀ» Çϸç, ÀÌ·± ÇൿÀ» ¼öÇàÄ¡ ¾ÊÀ» ½Ã, º»ÀÎÀÇ ÀÇÁö¿Í ¹«°üÇÏ°Ô ¸÷½Ã ºÒ¾ÈÇØÇϰí, ÃÊÁ¶ÇØÇÑ´Ù. |
||
| ¿µ¹® | panic disorder | ÇÑ±Û | °øÈ²Àå¾Ö |
|---|---|---|---|
| ¼³¸í | ¹Ýº¹µÇ´Â °øÈ²¹ßÀÛ(panic attack: °©ÀÛ½º·± °øÆ÷»óÅÂÀÇ ¹ßº´)°ú ½Å°æ°ú¹ÎÀ» ³ªÅ¸³»´Â °æ¿ì¸¦ ¸»ÇÔ. °øÈ²¹ßÀÛÀº ´Üµ¶À¸·Î ÀϾ±âº¸´Ù´Â ¿À·£ ±äÀå»óÅ¿¡¼ ÁÖ±âÀûÀ¸·Î ÀϾ´Â Çö»óÀ¸·Î º¸ÀδÙ. °øÈ²¹ßÀÛÀÇ Áõ»óÀº ±Þ°ÝÇÑ ÀÚÀ²½Å°æÀÚ±ØÁõ»óÀ¸·Î È£Èí°ï¶õ, ½ÉÀå¹Úµ¿Ç×Áø, ÈäºÎÅëÁõ, ÈäºÎ¾Ð¹Ú°¨, Áú½Ä°¨, Çö±âÁõ, ºÒ¾ÈÁ¤ÇÑ ´À³¦ µîÀÌ´Ù. ´ë°³ °©ÀÚ±â ÀϾ ¼öºÐµ¿¾È Áö¼ÓÇß´Ù°¡ ¼Ò½ÇµÇ´Â °ÍÀÌ º¸ÅëÀÌ´Ù. µå¹°°Ô´Â ¼ö½Ã°£ Áö¼ÓµÇ±âµµ ÇÑ´Ù. °øÈ²¹ßÀÛÀº ÁÖ±âÀûÀ¸·Î ¹Ýº¹µÇ¸é¼ ¸¸¼ºÈÇÏ´Â °æÇâÀÌ ¸¹´Ù. ½Å°æ°ú¹ÎÀº °øÈ²¹ßÀÛÀÌ ¾ø´Â ½Ã±âÀÇ Áõ»óÀÌ´Ù. °¨´çŰ ¾î·Á¿î °øÈ²¹ßÀÛ¿¡ ´ëÇÑ ¿¹±âºÒ¾È(±× ÀÏÀÌ ÀϾÁö ¾ÊÀ»±î ÇÏ´Â ´À³¦ ¶§¹®¿¡ ¿À´Â ºÒ¾È)ÀÌ ÀÖ°í ±× ¶§¹®¿¡ Á¶½É½º·¯¿öÁö°í ÁÖÀ§¸¦ »ìÇǴ ŵµµµ ³ªÅ¸³ª¼ ½Å°æÀº ±Øµµ·Î ³¯Ä«·Î¿öÁø´Ù. °øÆ÷Àå¾Ö¿¡¼µµ ÀÌ·± °øÈ²¹ßÀÛÀÌ ¿Ã ¼ö ÀÖÀ¸³ª, ÀÌ °æ¿ì´Â Ưº°ÇÑ ´ë»óÀ̳ª »óȲÀÌ ÀÖ´Â °Í¿¡ ¹ÝÇØ °øÈ²Àå¾Ö´Â ÀÌ·± Ưº°ÇÑ »ç°Ç¾øÀÌ ÁÖ±âÀûÀ¸·Î ¹ß»ýÇÑ´Ù. Ä¡·á´Â Ç׺ҾÈÁ¦¿Í ¶§·Î´Â Ç׿ì¿ïÁ¦¸¦ »ç¿ëÇÑ´Ù. |
||
| CD | cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise... |
|---|---|
| ADCC | acute disorder of cerebral circulation; antibody-dependent cell-mediated cytotoxicity |
| d/t | due to |
| dt | due to; dystonic |
| DUE | drug use evaluation |
| OA | Oral anticoagulants |
|---|---|
| DUE | DNA unwinding element |
| DUE | Drug usage evaluation |
| ECC | extra corporal circulation |
| EC | Extracorporeal circulation |
| lupus anticoagulants | Lupus anticoagulants are a common cause of a prolonged activated partial thromboplastin time (APTT) which is corrected by the addition of platelet -rich plasma (or phospholipids) and not by platelet-poor plasma. The methods of choice for detection of lupus anticoagulants are the kaolin clotting time using the rabbit brain neutralisation procedure and the dilute Russell viper venom test (dRVVT). Current data suggest that lupus anticoagulants and antibodies to negatively charged phospholipids (cardiolipin, phosphatidylserine, phosphatidic acid and phosphatidylinositol) are risk factors for arterial and venous thrombosis and for recurrent abortions in populations of patients which are distinct but overlapping. Drug-induced lupus anticoagulants are also associated with increased risk of thrombosis. Current testing for lupus anticoagulants and phospholipid antibodies (cardiolipin plus phosphatidylserine) may be useful for assessing risk in patients with systemic lupus erythematosus. Some data indicate that lupus anticoagulants assays are more reliable predictors of thrombosis, foetal loss and thrombocytopenia than are cardiolipin antibody (ACA) assays. Although the technology is in many ways more reliable, the rush to describe associations of lupus anticoagulants with various disorders has been much less scientifically unseemly than has been that of ACAs with their bewildering variety of clinical associations. The contribution of one serious study must, it seems, render tolerable the excess of trivia recently published in this area. See also cardiolipin antibodies and phospholipid antibodies. (05 Mar 2000) |
|---|---|
| due date | The estimated calendar date when a baby will be born, the date the baby is due to be born. It is also called the estimated date of confinement (EDC). (12 Dec 1998) |
| dystonia, focal, due to blepharospasm | The second most common focal dystonia, the involuntary, forcible closure of the eyelids. The first symptoms may be uncontrollable blinking. Only one eye may be affected initially, but eventually both eyes are usually involved. The spasms may leave the eyelids completely closed causing functional blindness even though the eyes and vision are normal. (12 Dec 1998) |
| dystonia, focal, due to torticollis | Spasmodic torticollis, or torticollis, is the most common of the focal dystonias. In torticollis, the muscles in the neck that control the position of the head are affected, causing the head to twist and turn to one side. In addition, the head may be pulled forward or backward. (12 Dec 1998) |
| thrombotic disease due to protein c deficiency | Protein C is a protein in plasma that enters into the cascade of biochemical events leading to the formation of a clot. Deficiency of protein c results in thrombotic (clotting) disease and excess platelets with recurrent thrombophlebitis (inflammation of the vein that occurs when a clot forms). The clot can break loose and travel through the blood stream (thromboembolism) to the lungs causing a pulmonary embolism, brain causing a stroke (cerebrovascular accident), heart causing an early heart attack, skin causing what in the newborn is called neonatal purpura fulminans, the adrenal gland causing haemorrhage with abdominal pain, abnormally low blood pressure (hypotension), and salt loss. Protein c deficiency is due to possession of one gene (heterozygosity) in chromosome band 2q13-14. The possession of two such genes (homozygosity) is usually lethal. (12 Dec 1998) |
| assisted circulation | Pumping that aids the natural activity of the heart. (12 Dec 1998) |
| blood circulation | The course of the blood from the heart through the arteries, capillaries, and veins back again to the heart. (05 Mar 2000) |
| blood circulation time | Determination of the shortest time interval between the injection of a substance in the vein and its arrival at some distant site in sufficient concentration to produce a recognizable end result. It represents approximately the inverse of the average velocity of blood flow between two points. (12 Dec 1998) |
| capillary circulation | The course of the blood through the capillaries. (05 Mar 2000) |
| renal circulation | The circulation of the blood through the vessels of the kidney. (12 Dec 1998) |
| respiratory circulation | The mechanisms of pulmonary circulation coordinated with the heart and systemic circulation. It involves the flow or interruption of the flow of blood to the lungs as it affects respiration. Pulmonary circulation, a circulatory concept, emphasizes the passage of blood from the right to the left heart through the lungs. Respiratory circulation coordinates this with heart action, systemic circulation, and breathing. (12 Dec 1998) |
| cerebrovascular circulation | The circulation of blood through the vessels of the brain. (12 Dec 1998) |
| greater circulation | The circulation of blood through the arteries, capillaries, and veins of the general system, from the left ventricle to the right atrium. Synonym: greater circulation. (05 Mar 2000) |
| persistent foetal circulation syndrome | <syndrome> A syndrome of persistent pulmonary hypertension in the newborn infant, without demonstrable cardiac disease. It is characterised by cyanosis and acidosis, severe pulmonary vasoconstriction, hypertrophy of pulmonary arterial muscle, and elevated pulmonary vascular resistance, with resultant right-to-left shunting of blood through a patent ductus arteriosus and at times a patent foramen ovale. (12 Dec 1998) |
| circulation | <physiology> Movement in a regular or circuitous course, as the movement of the blood through the heart and blood vessels. Origin: L. Circulatio (18 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|